Considering the significant growth potential in New York's cannabis market and the strategic positioning of Multi-State Operators (MSOs) highlighted in Zuanic & Associate's latest report, how might investors capitalize on these burgeoning opportunities?
New York State's Cannabis Market: An Overview
The state may open more than 1,000 recreational stores, considering the current 31 stores, 400 Conditional Adult-Use Retail Dispensary (CAURD) licensees and additional applications.
This expansion offers substantial opportunities for entities with the resources and capacity for wholesale trade.
Current medical incumbents, comprising 10 MSOs, can enter the recreational market by paying a total of $20 million.
Estimations in Zuanic’s report suggest New York could house up to 600 stores based on California's density, or potentially more than 3,600 stores if it follows Colorado's model.
The Potential for MSOs in New York
The outlook for Multi-State Operators (MSOs) in New York presents a complex scenario, as explained by Zuanic.
While oversupply and tough economic conditions in markets such as California and Michigan could temper enthusiasm, the unique regulatory environment and current challenges in capital access in New York may work in favor of MSOs.
Pablo Zuanic, senior analyst, explained that MSOs will face negotiations with landlords and regulatory hurdles, but so will other retail licensees, potentially giving MSOs an advantage.
However, the short-term outlook for wholesale opportunities appears less promising, given the well-stocked nature of existing recreational stores and current cultivation capacity.
Medical Cannabis Market Dynamics
Registered Organizations (ROs), which are medical incumbents permitted to operate four medical stores each, are preparing to enter the recreational market.
This transition involves varied costs and strategic decisions, with companies like Goodness Growth GDNSF, iAnthus ITHUF and MedMen MMNFF currently financially constrained.
Other public MSOs like Curaleaf CURA and The Cannabist (fmr. Columbia Care) CCHWF are gearing up to offer recreational services at selected stores.
Medical Wholesalers and Retail Dynamics
The medical wholesale market is dominated by a few large suppliers, with Curaleaf leading in product listings. The analysis of medical store menus indicates a concentration of supply among a handful of providers.
As for the retail landscape, New York currently has 31 recreational stores, with the possibility of hundreds more opening following recent legal rulings.
Recreational Wholesale Prospects for MSOs
The success of MSOs in the recreational wholesale market will depend on the pace of new store openings and their ability to meet the demands of a well-supplied market.
Companies like Columbia Care, Curaleaf, and Green Thumb Industries GTBIF are positioned favorably in this space, with existing cultivation and manufacturing capacities.
"In terms of the wholesale opportunity, we are less bullish in the short term. Just looking at store menus, it would seem the current 31 rec stores are quite well stocked in SKUs and brands. Also, we understand rec cultivation is at 380 acres, and 400 acres are needed for every 100 stores,” Zuanic wrote.
"Still, if the store pace ramps (a factor to monitor, but not a certainty), and capital access limits the ability of new recreational grower licensees to expand, then in that instance MSO incumbents could benefit Curaleaf, Cannabist, Green Thumb," he added.
However, Zuanic warned the market seems adequately supplied for the time being, both in quantity and quality.
Current State of Recreational Stores
The existing recreational stores in New York, which have generated sales of $83 million since late December 2022, showcase a well-supplied market with a diverse range of products and brands.
These stores face competition from both legal and illicit markets, with the latter estimated to include over 1,000 outlets.
Photo: AI-Generated Image.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!